MKI67 and non-small cell lung carcinoma: For all NSCLC patients, the low Ki-67 expression groups had a higher objective remission rate (ORR, 25.1 vs. 3.1%) and disease control rate (DCR, 59.7 vs. 11.7%) than the high Ki-67 expression groups.